Evidence map›Paper›PMID 42146463›Full record

ArticlebioRxiv : the preprint server for biology2026

Genetic suppression of myeloid receptor Clec7a attenuates microglia neuroinflammation and promotes microglial phagocytosis to delay disease progression in ALS models.

Xuan Chen, Huilan Yan, Haichao Wei, Sanaz Sajadi, Jingwen Hu, Vinicius Vasconcellos, Ashley Kim, Tarun Shriram, Huizhong Tan, Kyoeun Keum and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xuan ChenDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Huilan YanDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Haichao WeiDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77030, USA.
Sanaz SajadiDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Jingwen HuDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Vinicius VasconcellosDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Ashley KimDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Tarun ShriramDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Huizhong TanDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Kyoeun KeumDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.
Jiaqian WuDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77030, USA.
Martin PaukertDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Yongjie YangDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA, 02111.

Funding

CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)R01AG078728 · NIA · TUFTS UNIVERSITY BOSTON · PI ALEXEI DEGTEREV, Yongjie Yang · 2022 to 2026
$4.4M
Exosome-mediated propagation of disease linked poly-dipeptides in C9orf72-FTD/ALSRF1AG057882 · NIA · THOMAS JEFFERSON UNIVERSITY · PI TROTTI, DAVIDE, YANG, YONGJIE · 2018 to 2018
$3.6M
Dysfunctional Astroglial Exosome to (motor) Neuron Axon Signaling in ALSR01NS125490 · NINDS · TUFTS UNIVERSITY BOSTON · PI Yongjie Yang · 2022 to 2026
$2.1M
NIA NIH HHS R01 AG078728NIA NIH HHS RF1 AG057882NINDS NIH HHS R01 NS125490
6 · The paper itself

Abstract

Microglial activation has been closely associated with accelerated ALS disease progression. However, specific microglial pathways that regulate microglial activation and ALS disease progression remain limitedly understood. Here, we determined the role of Clec7a (or Dectin-1), a core signature gene of disease-associated microglia (DAM) in ALS, in regulating microglial activation and ALS disease progression. Our spinal cord scRNA-Seq results found that Clec7a deficiency specifically attenuated microglial neuroimmune gene expression in SOD1G93A mice and human ALS. In addition,

Identifiers

PMID42146463
PMCPMC13174279

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.